CAPTRUST Financial Advisors
FLGT icon

CAPTRUST Financial Advisors’s Fulgent Genetics FLGT Stock Holding History

CAPTRUST Financial Advisors’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-873
Closed -$48K – 2748
2022
Q2 		$48K Buy
873
+80
+10% +$4.4K ﹤0.01% 2792
2022
Q1 		$49K Sell
793
-1,215
-61% -$80K ﹤0.01% 2785
2021
Q4 		$202K Sell
2,008
-324
-14% -$28.5K ﹤0.01% 1631
2021
Q3 		$210K Buy
2,332
+892
+62% +$81.1K ﹤0.01% 1524
2021
Q2 		$133K Buy
1,440
+375
+35% +$29.9K ﹤0.01% 1803
2021
Q1 		$103K Buy
1,065
+262
+33% +$27K ﹤0.01% 1925
2020
Q4 		$42K Buy
803
+780
+3,391% +$32.6K ﹤0.01% 1904
2020
Q3 		$1K Sell
23
-1,977
-99% -$61.9K ﹤0.01% 2895
2020
Q2 		$32K Buy
+2,000
New +$30.6K ﹤0.01% 1782

Other funds holding FLGT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

CAPTRUST Financial Advisors's FLGT Position: Q3 2022 in Review

CAPTRUST Financial Advisors sold out of Fulgent Genetics (FLGT) in Q3 2022, closing a stake of 873 shares — an estimated $48K sold.

CAPTRUST Financial Advisors first reported a position in FLGT in Q2 2020 and held it in 9 quarters. The position peaked at $210K in Q3 2021. 235 funds tracked by Wall St. Rank hold FLGT as of Q3 2022.

  • CAPTRUST Financial Advisors reported no remaining Fulgent Genetics position as of Q3 2022 after selling out during the quarter.
  • CAPTRUST Financial Advisors sold 873 Fulgent Genetics shares in Q3 2022, an estimated $48K.
  • CAPTRUST Financial Advisors first reported a position in Fulgent Genetics in Q2 2020 and held it in 9 quarters.
  • CAPTRUST Financial Advisors's Fulgent Genetics position peaked at $210K in Q3 2021.
  • 235 funds tracked by Wall St. Rank held Fulgent Genetics as of Q3 2022.

Based on CAPTRUST Financial Advisors's 13F filing for Q3 2022, filed 16 Nov 2022.